TipRanks
Advertisement
Advertisement

PERCF Stock Latest News

Percheron Therapeutics Issues 300 Million New Shares to Institutional and Sophisticated Investors
Company AnnouncementsPercheron Therapeutics Issues 300 Million New Shares to Institutional and Sophisticated Investors
25d ago
Percheron Therapeutics to List 300 Million New Shares on ASX
PremiumCompany Announcements
Percheron Therapeutics to List 300 Million New Shares on ASX
26d ago
Percheron Therapeutics Sets Hybrid Annual General Meeting for October 2026
PremiumCompany Announcements
Percheron Therapeutics Sets Hybrid Annual General Meeting for October 2026
26d ago
Percheron updates investors as Vanderbilt trial advances HMBD-002
PremiumCompany Announcements
Percheron updates investors as Vanderbilt trial advances HMBD-002
1M ago
Percheron Therapeutics Plans Issue of 50 Million Quoted Options
PremiumCompany Announcements
Percheron Therapeutics Plans Issue of 50 Million Quoted Options
1M ago
Percheron Therapeutics Plans Major Share and Option Issuance on ASX
PremiumCompany AnnouncementsPercheron Therapeutics Plans Major Share and Option Issuance on ASX
1M ago
Percheron Therapeutics Plans Major Share and Option Issue on ASX
Premium
Company Announcements
Percheron Therapeutics Plans Major Share and Option Issue on ASX
1M ago
Percheron Therapeutics Details Equity Interests of New Director Deborah Ambrosini
Premium
Company Announcements
Percheron Therapeutics Details Equity Interests of New Director Deborah Ambrosini
1M ago
Percheron Therapeutics Cancels Unmet Options in Director Incentive Plan
PremiumCompany Announcements
Percheron Therapeutics Cancels Unmet Options in Director Incentive Plan
1M ago
Percheron Therapeutics Options Lapse Clarifies Future Dilution Profile
PremiumCompany Announcements
Percheron Therapeutics Options Lapse Clarifies Future Dilution Profile
1M ago
Percheron Seeks Trading Halt Ahead of Capital Raising Announcement
PremiumCompany Announcements
Percheron Seeks Trading Halt Ahead of Capital Raising Announcement
1M ago
Percheron taps Vanderbilt for AML trial of VISTA antibody HMBD-002
PremiumCompany Announcements
Percheron taps Vanderbilt for AML trial of VISTA antibody HMBD-002
1M ago
Percheron Therapeutics Corrects Auditor Report Omission in FY2026 Annual Filing
PremiumCompany AnnouncementsPercheron Therapeutics Corrects Auditor Report Omission in FY2026 Annual Filing
1M ago
Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G
Premium
Company Announcements
Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G
2M ago
Percheron Therapeutics Adds New Shares to ASX Quotation
Premium
Company Announcements
Percheron Therapeutics Adds New Shares to ASX Quotation
2M ago
Percheron Therapeutics names Michael Baker CEO as James Garner moves to non-executive role
PremiumCompany Announcements
Percheron Therapeutics names Michael Baker CEO as James Garner moves to non-executive role
2M ago
Percheron Advances Lead Cancer Drug Minperstobart and Raises $2.2m for New Trial
PremiumCompany Announcements
Percheron Advances Lead Cancer Drug Minperstobart and Raises $2.2m for New Trial
2M ago
Percheron Completes Manufacture of HMBD-002 Drug Substance for 2026 Trial
PremiumCompany Announcements
Percheron Completes Manufacture of HMBD-002 Drug Substance for 2026 Trial
4M ago
Percheron Therapeutics Issues New Tranche of Unquoted Equity Securities
PremiumCompany Announcements
Percheron Therapeutics Issues New Tranche of Unquoted Equity Securities
4M ago
Percheron Therapeutics Plans Issue of 13.75 Million Options to Bolster Capital
PremiumCompany AnnouncementsPercheron Therapeutics Plans Issue of 13.75 Million Options to Bolster Capital
4M ago
WHO assigns proposed nonproprietary name to Percheron’s cancer drug HMBD-002
Premium
Company Announcements
WHO assigns proposed nonproprietary name to Percheron’s cancer drug HMBD-002
4M ago
Percheron Therapeutics Updates Market on Lapse of 600,000 Options
Premium
Company Announcements
Percheron Therapeutics Updates Market on Lapse of 600,000 Options
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >